March 04, 2015 1:54 PM ET

Pharmaceuticals

Company Overview of Zyngenia, Inc.

Company Overview

Zyngenia, Inc., a biopharmaceutical company, engages in the development of multi-specific antibody-based drugs in the United States. It focuses on the development of therapies for various cancers and autoimmune disorders. The company was incorporated in 2008 and is based in Gaithersburg, Maryland.

21 Firstfield Road

Suite 200

Gaithersburg, MD 20878

United States

Founded in 2008

Phone:

410-467-1176

Key Executives for Zyngenia, Inc.

Chairman of the Clinical Advisory Board, Acting Chief Executive Officer and Director
Age: 64
Chief Business Officer
Age: 55
Vice President of Biopharmaceutical Research & Assay Development
Chief Scientific Officer
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
AREVA Med LLC United States
Advantagene, Inc. United States
Piedmont Pharmaceuticals LLC United States
ConAgra Functional Foods, Inc. United States
Tyler Distribution, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Zyngenia, Inc., please visit www.zyngenia.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.